易瑞生物 (300942.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(易瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 69.0056.0025.0031.0047.0060.0067.00
 单季度销售净利率(%) -56.00-81.00-46.00-57.00-3.0021.0039.00
 单季度净资产收益率ROE(%) -3.00-5.00-3.00-7.00-4.0011.00
 单季度总资产净利率ROA(%) -2.00-3.00-2.00-5.00-3.009.00
单季度财务摘要:
 单季度营业总收入(元) 52,987,958.0051,403,742.0060,707,585.00114,802,873.0097,425,577.00180,667,812.00294,001,216.00
 单季度营业总成本(元) 59,674,367.0090,638,272.0094,325,424.00145,145,412.00114,504,103.00140,599,691.00155,220,845.00
 单季度营业收入(元) 52,987,958.0051,403,742.0060,707,585.00114,802,873.0097,425,577.00180,667,812.00294,001,216.00
 单季度营业利润(元) -11,293,364.00-50,258,759.00-33,534,214.00-77,928,920.00-8,541,032.0045,297,052.00139,280,318.00
 单季度利润总额(元) -12,243,744.00-50,551,672.00-33,443,386.00-81,189,951.00-8,544,340.0045,312,349.00139,308,120.00
 单季度净利润(元) -29,540,722.00-41,590,495.00-28,085,395.00-65,628,156.00-3,067,614.0037,261,267.00114,098,298.00
 单季度归属母公司股东的净利润(元) -29,526,261.00-41,571,178.00-28,061,115.00-65,399,274.00-3,048,995.0037,284,787.00114,128,972.00
 单季度经营活动产生的现金流量(元) 13,379,572.00-17,777,653.00-53,990,719.00120,744,715.0015,336,419.0067,650,627.00-51,177,229.00
 单季度投资活动产生的现金流量(元) 68,174,288.00-2,709,595.0023,962,685.00-66,488,806.00-69,373,574.00-70,041,259.0015,956,036.00
 单季度筹资活动产生的现金流量(元) 340,367,797.0029,389,176.00-4,219,736.00-145,526.0035,812,362.00--
 单季度现金及现金等价物净增加(元) 419,455,946.0017,297,468.00-35,383,062.0041,594,207.00-12,226,801.00-86,169,009.00-35,248,171.00

前瞻产业研究院